BAMOSIRAN
UNII C8Q2RMU41O

Substance Identification & Data

This profile provides standardized clinical and technical data for Bamosiran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C8Q2RMU41O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1337968-84-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
C8Q2RMU41O
CAS Registry Number
1337968-84-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BAMOSIRAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171793
National Cancer Institute reference terminology for clinical and research data.
INN ID
9534
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bamosiran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BAMOSIRAN

Common Names & Synonyms

BAMOSIRAN [INN]
BAMOSIRAN [WHO-DD]
RNA, (C-A-U-U-G-U-G-C-A-U-G-U-G-A-U-C-C-A-G-DT-DT), COMPLEX WITH RNA (C-U-G-G-A-U-C-A-C-A-U-G-C-A-C-A-A-U-G-DT-DT) (1:1)

Technical Codes

SYL040012
SYL-040012

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus